ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Opko Health Inc

Opko Health Inc (OPK)

1.43
0.05
(3.62%)
Closed July 15 4:00PM
1.44
0.01
( 0.70% )
Pre Market: 5:53AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.44
Bid
1.42
Ask
1.44
Volume
151
0.00 Day's Range 0.00
0.8516 52 Week Range 2.22
Market Cap
Previous Close
1.43
Open
-
Last Trade Time
04:39:42
Financial Volume
-
VWAP
-
Average Volume (3m)
3,490,318
Shares Outstanding
696,991,677
Dividend Yield
-
PE Ratio
-5.28
Earnings Per Share (EPS)
-0.27
Revenue
864.53M
Net Profit
-188.86M

About Opko Health Inc

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operatio... OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Opko Health Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker OPK. The last closing price for Opko Health was $1.43. Over the last year, Opko Health shares have traded in a share price range of $ 0.8516 to $ 2.22.

Opko Health currently has 696,991,677 shares outstanding. The market capitalization of Opko Health is $996.70 million. Opko Health has a price to earnings ratio (PE ratio) of -5.28.

Opko Health (OPK) Options Flow Summary

Overall Flow

Bullish

Net Premium

71k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

OPK Latest News

NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner

NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner PR Newswire COCONUT GROVE, Fla...

OPKO Health to Participate in the Jefferies Global Healthcare Conference

MIAMI, May 31, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Global Healthcare Conference, being held June 4-6...

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2024. First quarter business...

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2024 after the close of the U.S...

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business PR Newswire BURLINGTON, N.C. and MIAMI, March 28, 2024 Transaction to enhance Labcorp's laboratory...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.1410.76923076921.31.471.2734319171.37759367CS
40.216.12903225811.241.471.1930815181.29095724CS
120.2117.07317073171.231.471.1534903181.30550888CS
260.46547.69230769230.9751.470.860165671831.10801819CS
52-0.63-30.43478260872.072.220.851660207521.15447999CS
156-2.15-59.88857938723.595.250.851644529692.03586107CS
260-0.72-33.33333333332.166.470.851663611442.75428014CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CDTConduit Pharmaceuticals Inc
$ 0.4486
(86.92%)
20.37M
WNWMeiwu Technology Company Ltd
$ 1.23
(38.20%)
2.22M
SYRASyra Health Corporation
$ 1.75
(31.09%)
1
WLDSWearable Devices Ltd
$ 0.532
(23.32%)
412.57k
WINTWindtree Therapeutics Inc
$ 4.50
(21.62%)
10
GRNQGreenpro Capital Corporation
$ 0.9665
(-18.09%)
80.61k
AMIXAutonomix Medical Inc
$ 1.14
(-17.39%)
419.04k
AREBAmerican Rebel Holdings Inc
$ 0.561
(-16.64%)
143.83k
CYNCYNGN Inc
$ 7.82
(-14.81%)
12.26k
MFImF International Ltd
$ 0.80
(-14.44%)
3.1k
CDTConduit Pharmaceuticals Inc
$ 0.4573
(90.54%)
20.32M
KRKR36Kr Holdings Inc
$ 0.3125
(5.15%)
4.57M
SLNASelina Hospitality PLC
$ 0.0662
(5.75%)
2.45M
WNWMeiwu Technology Company Ltd
$ 1.23
(38.20%)
2.22M
MAXNMaxeon Solar Technologies Ltd
$ 0.2211
(-2.60%)
1.46M

OPK Discussion

View Posts
homeboy homeboy 2 weeks ago
Hey Mike. I think the 80 million is the value of their holdings in WGS. Not bad,
👍️0
MIKE18181 MIKE18181 3 weeks ago
Frost made Money by having others perform the Finance. Hes Incompetant look at the resulrs. Frost got a free ride of otjers expertise.He is a Liar, farce, bullshetter.m He nows zip about financial mgmt. Hes a Fraud, and harmed shareholders. Going concern rating on broke Opk is a FACT !! A Fact !!!
👍️0
MIKE18181 MIKE18181 3 weeks ago
IMO, the 80million shares of Genedx is going to be unloaded. Word on the street is Opko is insolvent.. 155m in adj revenue and - 81million loss this is a horror show.
👍️0
game7alcs game7alcs 3 weeks ago
Hey Tred, good to hear from you. Yea it’s kind of a moot point that regardless of what is going on here, the shareholders are the ones getting the shaft. As usual.
👍️0
homeboy homeboy 3 weeks ago
OPK (Opko) short interest is very high.
👍️0
homeboy homeboy 3 weeks ago
Current Issues with OPK:
1). The part lab sale will lead to more cash on hand, but will it lead to better management and profitability of the remaining lab structure? 2) OPK last quarter issued 250 million shares to the treasury. OPKO is running out of cash on hand and will use these shares to fuel the company if needed. 3). WE expect that if the sale of the part lab is not done before the next conference call the stock will sell off and investors will take a wait and see approach.
👍️0
tredenwater2 tredenwater2 3 weeks ago
Game and Mike there is a possible chance that HF’s and other BP are suppressing the shareprice as a takeover maneuver to get at Opko’s IP. Dr. Frost Im sure has made or attracted many “future friends” along the way. History and God will be his judge and yes, I feel sorry for those that over invested and got taken to the cleaners and agree that not holding ones breath waiting for the halls of justice to save us is a good idea. We are but sucker fish on the smallest of bait in the sea when it comes to their priorities if ever.

Cheers

Tred
👍️0
game7alcs game7alcs 3 weeks ago
If you think Dr Frost is corrupt you should take a look at our DOJ, SEC and other govt agencies. They make Dr Frost look like Mother Theresa. They aren’t going to help the shareholders here recover from a bad investment in a highly speculative company.
👍️0
MIKE18181 MIKE18181 4 weeks ago
Department of justice (DOJ, SEC and more). We dont want an anti trust or monopoly or unfair business / competion that hurts consumers !!!

Ok, listen.. but you allow a CEO Phillip Frost to control the common stock, Mislead, Lie , Harm hardworkibg shareholders..
Look at the results since 2006.
Should have been fired for losses to all Opk shareholders. " to be held accoutable for lack of performance "...
👍️0
MIKE18181 MIKE18181 4 weeks ago
Takeout price is 3.00 IMO
👍️0
homeboy homeboy 1 month ago
Looks like a positive turn of events while we were away. They are setting this up for an eventual sale..perhaps not this year, but I think it’s coming. Probably an all stock offer from some other Pharma company. I don’t see anyone offering them cash for a company that hasn’t and isn’t making money. This endeavor for the Dr. has been a colossal failure for most investors. A lot of hype over the years and not delivering on the goods. Take care everyone. We’ll hold our position until we see a good exit point.
👍️0
tredenwater2 tredenwater2 3 months ago
Makes one wonder after looking at the trading pattern of CDXC (whom Dr. Frost is connected with) if OPK will do the same in the near future. Transfer of wealth in a very coordinated manner imo.
👍️0
tredenwater2 tredenwater2 3 months ago
What a shet show! Millions and millions of shares trade on Monday and 10 million plus today and the stock barely climbs. Let me guess, it was a quadruple whitching Monday and the moon was full? I have to admit I have never seen trading like this, is this even legal?

This stock is flat out evil. Whoever is manipulating it is surely going to hell in a hand basket. Outright greed imo strip mining shareholders of absolutely any chances here. Not even fun to watch the crazy shenanigans going on.

Ive lost the last 2.5% respect I had for Dr. Frost and team of which 1.5% of it was for Dr. Jane Hasao. They could solve world hunger and I wouldnt even bat an eye. This is text book bullshet!
👍️0
tredenwater2 tredenwater2 4 months ago
If that is true it is very sad to hear Mike. I lost money a couple of times but was able to profit very early in 2015/16 before the HFT AI trading took over. You are but one of many that have been systematically “cycled” out of their money. The trading of this stock appears to be so robotic, almost programmed through AI squeezing every last penny out of investors. Maybe one day Dr. Frost will have to answer here on earth for why he was so incompetent at the helm of a company he holds and continues to buy many millions of shares of stock of.

Do not worry, God will “settle” his trades.

Happy Easter!

Tred
👍️0
MIKE18181 MIKE18181 4 months ago
I sold every Opko share and Lost 437,000 dollars and my retirement money is all gone.
I sold all of it at 90 cents down to 86 cents.
Wiped out.. and then it went up to 1.25
Even at 1.25 I still lost 95 % .
Frost got away with it! SEC would not award me 1.00 buck
👍️0
MIKE18181 MIKE18181 4 months ago
88 cents and dropping. Chart momentum was showing it even with Frost buying.
Not looking good.
👍️0
MIKE18181 MIKE18181 4 months ago
Yes, I wrote about Yvonne Briggs IR, and said as I asked a simple question, I started to probe other harder.
Result backed off, and told me to read the Q reports . I called you, because you the Investir relation support. I got more calls gotta go.
This will be sold and the time frame to me looks like 2 qtrs
👍️0
homeboy homeboy 4 months ago
The reason we ask questions directly to management is there is an underlying tone that is not open with this company. I highlighted that with Adam Logal during the conference call mentioning the repurchase of shares. That was a deflection from what was really going on… Yvonne tries to come across as being open at the investor relations department. As a former business owner, I can assure you what you get from investor relations is scripted to what has been publicly released only. Behind the scenes is a different world. We (our team of investors) are betting on some type of buyout. Elias is in his 70s, Frost is near 90. Those are the main characters. Both cut from the same mold…grow the business, then sell it. Very common practice.
What Yvonne tells about the current outstanding shares is only part of the story. In a buyout, many of those reserved shares would also have to be honored. So, being conservative 1,000,000,000 shares at this point would be the buyout amount. For example: a buyout at 7 dollars would represent a 7 billion dollar purchase. Modex has value potential we think. As many here have said, the lab has been a nemesis and OPKO has not reacted fast enough. There was a reason the former owner was happy to sell Bio for 1.5 billion. We can see clearly now. But what remains a mystery is why OPKO continues to fund it at a deficit in the hundreds of millions? On another note…
We will be traveling for a while until mid June to China. Until then, hopefully OPKO will have some good fortune during the interim.
👍️0
MIKE18181 MIKE18181 4 months ago
Good information Homeboy, I talk about that a while back. I knew that the casflow statements and Income statement never were fixed.... Issuance was the only quick savior.
This 1,000,000 share buying is not going to solve the perception from the destroyed Audience.
A sold company would...
👍️0
homeboy homeboy 4 months ago
I inquired about the specifics to increase the share count:

“The Board has unanimously adopted and declared advisable, and has recommended that the Company's stockholders approve, the Charter Amendment, which would amend the Certificate of Incorporation to increase the number of authorized shares of common stock from 1,000,000,000 to 1,250,000,000.

In addition to the 726,764,700 shares of common stock issued and outstanding (including treasury shares) as of the record date, the Board has reserved an aggregate of 418,733,078 additional shares for future issuance, consisting of the following: (a) 53,731,069 shares reserved for issuance upon the exercise of outstanding employee stock options; (b) 32,912,579 shares reserved for future issuance of awards under the 2016 Equity Incentive Plan; (c) 48,295 shares reserved for issuance upon conversion of the Company's outstanding 4.50% convertible senior notes due 2025 issued in February 2019; (d) 8,489 shares reserved for issuance upon conversion of the Company's outstanding 2033 convertible senior notes issued in January 2013; and (e) 332,032,646 shares reserved for issuance upon conversion of the Company's outstanding 3.75% Convertible Senior Notes due 2029 issued in January 2024.

As a result, the Company currently has no authorized but unissued shares of common stock (including treasury shares) that are unreserved and available for future issuance.”
👍️0
MIKE18181 MIKE18181 4 months ago
This stock Opko is getting spanked , I hope something is coming. . 775m @ 2bucks 3 4 5 6 7 8 × the outstanding or unload BRL.
Genedx holdings went way up after 1.16 slide.
So, they don't need just cash they need a SANE financial plan..
👍️0
game7alcs game7alcs 4 months ago
Dr Frost has absolutely nothing zero nadda up his sleeve. I check back once in a while and still the same nonsense. Sell. Get out with what little you have left.
👍️0
homeboy homeboy 4 months ago
Frost must have something up his sleeve. He alluded to that without letting the cat out of the bag during the conference call. We are holding our position. A little under water.
👍️0
MIKE18181 MIKE18181 4 months ago
Yes, I also paid attention to what Elias said.
And the chang up to this year. I heard last year by the 1st quarter of 24. . These continued misses is why recommending from a brokerage to clients, Institutional and the public they sold and lowered holdings . Did here it right.
1.4 m on pfe 3rd qtr / and 12m on q4 pfe
Covering the expenditures from this, needs a budget . Weight loss drug, good luck !
👍️0
homeboy homeboy 4 months ago
Elias, whom I like, a year ago talked about being at break even with the lab by 2024. That didn’t happen and in the last conference call he regurgitated his remarks from a year ago that to be profitable sometime this year. Price reflects the lack of execution. The lab is the cause for the price as you say Mike..it has been choking OPKO since the purchase. Frost mentioned the lab was making 100 million a year at the time of purchase…I am starting to have my doubts about that statement.
With the new note deal, Frost will have/has more than 300 million shares. Logal wanted to highlight during the recent conference call that OPKO bought back 50 million shares with the note deal. That is just part of the deal. He failed to mention OPKO also had to reserve approximately 200 million just in case the notes are not repurchased. Dilution possibly to the tune of 150 million shares give or take.
Like you mentioned Mike, something has to give. One of the stocks we owned was KOPN and during the pandemic it went below 40 cents and on a squeeze went to 12 bucks before retreating. Frost stated the repurchase of the 50 million shares would put a floor in on the stock price right about where it is. There is 94 cents below the floor??
👍️0
MIKE18181 MIKE18181 4 months ago
.93 cents Dude.. Does the cash on hand and upcoming losses gonna give this a down draft.
Some analyst believe .-30 for 2024 FY
Dicey or play the rocking chair trades
Back and forth. Back to 1.00 or 1.01
Regardless, IMO this can't last much longer
👍️0
homeboy homeboy 4 months ago
“Market makers can influence stock prices by buying or selling stocks in large trading volume.”
👍️0
MIKE18181 MIKE18181 5 months ago
Exactly, I said 3 quarters of cash. Yes concern for the burn. If you being choked, pull the hand from your throat. The point is they will collapse without action. This is Bad man.
Cheap got cheaper, and more cheaper.
Wedsday trading will be down
👍️0
MIKE18181 MIKE18181 5 months ago
Exactly, I said 3 quarters of cash. Yes concern for the burn. If you being choked, pull the hand from your throat. The point is they will collapse without action. This is Bad man.
Cheap got cheaper, and more cheaper.
Wedsday trading will be down
👍️0
homeboy homeboy 5 months ago
Conference call revealed, reading between the lines, there is about 2 quarters of cash on hand to carry the losses. One analyst asked about disengaging from Bio and becoming a pharma only business. Take care everyone.
👍️0
MIKE18181 MIKE18181 5 months ago
Price to book ratio is .57, 1.00 is acceptable.
Investors say look Opko is Undervalued.
The real detection is " Financial distress "..
Be careful, and yes it could punch the wallet even more Cheap means something, and nobody is beating a path to buy at under a Buck..
It's mismanaged and Risky..
👍️0
homeboy homeboy 5 months ago
Revenue matches market cap pretty much. Thinking it can’t go lower can be dangerous to the wallet. Market makers will release the leash when they see fit. OPKO management is not moving fast enough to cure the constant loss per quarter. The note deal was self serving…and we will never know the full details. Warrants for the 230 mil at 5 bucks a share would have been a healthy way to instill trust. I don’t blame Frost for doing what he did. This company would have dried up long ago without his money. Have a good week…earnings Tuesday after market. Although they are guided to lose money the best we can expect is that they beat the loss and good news of some sort for the near future. Take care.
👍️0
MIKE18181 MIKE18181 5 months ago
Opko stock will be on sale this week.
👍️0
homeboy homeboy 5 months ago
Not sure what they think they can accomplish with NextPlat in a country where the government owns all the land (people can buy a home, but not the land), and people are poor. I’m not expecting anything money wise to come from this. We are in a bear trap…the only way out is good corporate news. Take care everyone.
👍️0
game7alcs game7alcs 5 months ago
Yea you can’t. Teaming up with this company is the act of a penny stock company. That’s all I think. Hope you bought cheap shares and don’t lose much like most people have.
👍️0
MIKE18181 MIKE18181 5 months ago
Opko selling dog food? Is it true ?? and do they want to just set up a Limited Partnership to " short there own stock somemore" .
I hope there is a mention of financial Eps impact
When can you believe these guys about any development.??
👍️0
game7alcs game7alcs 5 months ago
Are you excited about OPKO selling pet food. To da moon lol
👍️0
homeboy homeboy 5 months ago
Thanks Mike and good analogy.
👍️0
homeboy homeboy 5 months ago
The 2019 notes they recently bought were to be converted at $4.22 a share.

Not one comment from an analyst regarding this recent note deal. Hmmm
👍️0
MIKE18181 MIKE18181 5 months ago
Homeboy, great post ! It's accurate of what you see, what I see and what institutional investors see, analysts see. .. Everything he buys, it admits something Lacks.. To over compensate for mismanagement.

**Movie theatre analogy, 26 tickets sold to watch the movie and nobody came except Phil Frost. " he bought up 26 movie tickets and sat in an empty theater. The point, somethings needs to be done to get people to come. Denial runs Opko...
👍️0
MIKE18181 MIKE18181 5 months ago
I used to do well 20 to 35% annual growth on a 5 year run. Or consistant growth of 15 % .
Eps, and revenue with a solid ranking !
Translation: investors become interested.
Ranking of between 1 the best and 5 sell..
Opko, is ranked based on truthful performance
Year over year. It doesn't delivers.
The stock price tells the truth, and its true !.
👍️0
homeboy homeboy 5 months ago
Sent today to OPKO in response to your post:
You can buy all the shares as you wish, but a stock without earnings and revenue growth goes south.

OPKO is a penny stock and mismanagement is to blame.
If you have a consistent flow of income from the lab (per Adam Logal) can’t you figure out how to manage to be consistently profitable?? I sent a video of Dr. Frost in a Mad Money interview with Jim Cramer…stating the lab at purchase time had a revenue of one billion and income of 100 million. WHAT HAPPENED???????????
You’ll get the accolades too …not much to speak of at the moment.

OPKO has relationships with major pharmaceutical companies. Perhaps sell the company..or spin off Modex. Do something constructive. Hedge funds are showing no interest even at this price of pennies a share. The hedge funds want to see consistent revenue growth and profitability. Until then, do you think insiders buying shares will attract them? NOT without revenue growth and profit. Hedge funds move the stock..they are Wall Street.

Put someone on the board from a major pharmaceutical company…not just management being the board and calling all the shots. Do something!
👍️0
homeboy homeboy 5 months ago
Earnings and revenue growth are the most important factors to consider I think…although insider buying is a positive, it’s not what ultimately drives investors to a stock.
👍️0
MIKE18181 MIKE18181 5 months ago
Frost bought 1.500.000 today. Big Deal !
I can't manage so I'll buy, it will fix the finances.
You got alot of supply to go Phil. At 5m a week the stock might settle at 1.05..
350million more supplybthat nobody wants Phil.
You burned every bridge. Nobody is listening anymore. Your a Crook. Even your emoyees don't want to come to work .
👍️0
MIKE18181 MIKE18181 5 months ago
A rip down, for MM scooping. They could not go farther than 1.00 . So, the rip down, blowout stop orders scoop at .92 cents and resell this after a floor is put in and sell off the scooped stock. Pathetic operations. Opko is poorly managed
👍️0
homeboy homeboy 5 months ago
Well orchestrated bear raid this morning..perhaps to get the weak hands out.
👍️0
homeboy homeboy 5 months ago


Hopefully the link works. Frost states at the time of acquiring BioReference revenues were at a billion dollars and income 100 million.
I sent this to Frost himself. It just shows the management was not and has not been in place to maintain, grow, and execute.
👍️0
MIKE18181 MIKE18181 5 months ago
Yes, very good written posts. Search for efficiency. Find ways to see inefficient operations
CFO is an ass pirate, a puppet, a wuss.
CEO is highly ineffective. " if I keep buying shares, I'll get attention. No, the bottom line should bother you dto react . You don't react.
1.00 dollar or 98 cent company.
Buyout, replace the CEO , or go under..
Acsale looks correct. 690m × 5 00 a share buyout is 3.5 billion. Maybe..
👍️0
homeboy homeboy 5 months ago
Comparing hours of operation between BioReference Labs and Walmart:

Walmart Supercenter
4.0
Department Store
Opening hours ^
Sunday
6AM-11PM
Monday
6 AM-11 PM
Tuesday
6 AM-11 PM
Wednesday
6 AM-11 PM
Thursday
6 AM-11 PM
Friday
6 AM-11 PM
Saturday
6 AM-11 PM

————————-

BioReference®

Closed for lunch M-Th: 10:30AM -
11:15AM

Sunday
Closed


Monday
6:00 AM
2:30 PM

Tuesday
6:00 AM
2:30 PM

Wednesday
6:00 AM
2:30 PM

Thursday
6:00 AM
2:30 PM

Friday
6:00 AM
10:00 AM

Saturday
Closed
👍️0
homeboy homeboy 5 months ago
Buyout
I think OPKO will eventually get bought out. That is Frost’s MO. He’s 88 now and not much time left to control the company. He’s got plenty of shares. It’s just a matter of lining up the stars. My opinion based on Frost’s past record. We are holding our shares bought at a dollar.
👍️0

Your Recent History

Delayed Upgrade Clock